The National Institute for Excellence in Health and Care (NICE) has recommended an electrocardiogram (ECG) based on smartphones as an option to detect atrial fibrillation within the NHS outpatient setting.
KardiaMobile’s AI-enabled platform can support patients and physicians by providing remote access to a medical-grade ECG. It allows people with suspected paroxysmal atrial fibrillation (AF), where symptoms such as palpitations are intermittent, to control their heart activity at home.
This means that AF can be detected more quickly, and with a faster diagnosis, patients are better protected against any AF-related health condition. Technology can also eliminate the need for regular hospital appointments, allowing users to monitor their own health.
Users only need to place both fingers on each hand where indicated on the smartphone to capture a 30-second ECG recording. This can provide instant detection of atrial fibrillation (AF), bradycardia and tachycardia, key indicators of cardiovascular disease.
ECG recordings can be reviewed by a healthcare professional and the results are used to support clinical decision making.
Professor Matt Reed, a consultant and NRS member of emergency medicine at NHS Lothian, said: “With the NHS exaggerated, it is encouraging that NICE has recognized the value of using smart technology to support “Today ‘s recommendation from KardiaMobile, a clinically validated digital tool to enable people to control their heart rate at home, avoiding the need for hospital appointments, is a big step forward for cardiac services.”
KardiaMobile comes from AliveCor, whose business platform allows third-party providers to manage patients’ heart conditions with state-of-the-art tools that offer easy front and back integration with AliveCor technologies.
Priive Abani, CEO of AliveCor, added: “AliveCor is proud to be able to offer the only personal ECG recommended by NICE to support remote cardiac care services for patients who are not in front of their cardiologist.”
He continued: “(This) recommendation not only highlights the clinical superiority of KardiaMobile over the current standard of care, but also its position as the most cost-effective solution, therefore guaranteeing its value as a clinical tool to give support for rapid diagnosis of AF. ”
An ECG pilot of the KardiaMobile smartphone found that yes five times more effective at diagnosing heart problems, than standard tests.
